ATE354096T1 - Synthese und screening von liganden mit hilfe von röntgenkristallographie - Google Patents

Synthese und screening von liganden mit hilfe von röntgenkristallographie

Info

Publication number
ATE354096T1
ATE354096T1 AT03782663T AT03782663T ATE354096T1 AT E354096 T1 ATE354096 T1 AT E354096T1 AT 03782663 T AT03782663 T AT 03782663T AT 03782663 T AT03782663 T AT 03782663T AT E354096 T1 ATE354096 T1 AT E354096T1
Authority
AT
Austria
Prior art keywords
macromolecule
crystal
ligands
screening
synthesis
Prior art date
Application number
AT03782663T
Other languages
English (en)
Inventor
Harren Jhoti
Miles Stuart Congreve
Marc O'reilly
Paul Graham Wyatt
Original Assignee
Astex Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0230172A external-priority patent/GB0230172D0/en
Application filed by Astex Therapeutics Ltd filed Critical Astex Therapeutics Ltd
Application granted granted Critical
Publication of ATE354096T1 publication Critical patent/ATE354096T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03782663T 2002-12-23 2003-12-22 Synthese und screening von liganden mit hilfe von röntgenkristallographie ATE354096T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43534902P 2002-12-23 2002-12-23
GB0230172A GB0230172D0 (en) 2002-12-24 2002-12-24 Synthesis and screening of macromolecules

Publications (1)

Publication Number Publication Date
ATE354096T1 true ATE354096T1 (de) 2007-03-15

Family

ID=32683994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03782663T ATE354096T1 (de) 2002-12-23 2003-12-22 Synthese und screening von liganden mit hilfe von röntgenkristallographie

Country Status (6)

Country Link
US (1) US7149280B2 (de)
EP (1) EP1576375B1 (de)
AT (1) ATE354096T1 (de)
AU (1) AU2003290304A1 (de)
DE (1) DE60311879T2 (de)
WO (1) WO2004057340A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2521766A1 (en) * 2003-04-11 2004-10-28 Sgx Pharmaceuticals, Inc. Compound libraries and methods for drug discovery
US20060269942A1 (en) * 2005-04-27 2006-11-30 Kolb Hartmuth C In situ click chemistry method for screening high affinity molecular imaging probes
JP2021081369A (ja) * 2019-11-21 2021-05-27 キリンホールディングス株式会社 求核基を有する化合物の結晶スポンジ法による構造解析のための結晶構造解析用試料の調製方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958702A (en) * 1995-02-06 1999-09-28 Benner; Steven Albert Receptor-assisted combinatorial chemistry
DE19619373A1 (de) 1996-05-14 1997-11-20 Hoechst Ag Neue Substanzbibliothek und damit hergestellte supramolekulare Komplexe
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
WO1999045389A2 (en) 1998-03-06 1999-09-10 Abbott Lab Ligand screening and design by x-ray crystallography
US6344330B1 (en) 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6335155B1 (en) 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
EP1141708A1 (de) 1998-12-28 2001-10-10 Sunesis Pharmaceuticals Inc. Auf avidität basierte verfahren und zusammensetzungen zur identifizierung von kleinen organischen ligandmolekülen, die biologische zielmoleküle binden
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6404849B1 (en) * 1999-08-11 2002-06-11 Abbott Laboratories Automated sample handling for X-ray crystallography
EP1130009A1 (de) 2000-03-01 2001-09-05 Therascope AG Erzeugung und Screenen einer dynamischen kombinatorischen Verbindungsbibliothek
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
EP1184359A1 (de) 2000-09-04 2002-03-06 Therascope AG Erzeugung von dynamischen kombinatorischen Verbindungsbibliotheken und deren Bewertung durch Dekonvolution
EP1337853B1 (de) 2000-11-21 2009-01-07 Sunesis Pharmaceuticals, Inc. Erweiterter "tethering" ansatz zum schnellen auffinden von liganden
US6546074B1 (en) 2001-03-27 2003-04-08 Astex Technology Limited Protein crystal structure and method for identifying protein modulators
US6950757B2 (en) * 2001-04-11 2005-09-27 Emerald Biostructures, Inc. Screening methods for identifying ligands
EP1308716A1 (de) * 2001-10-03 2003-05-07 Avantium International B.V. Verfahren und Vorrichtung zur Durchführung einer Transmissions- Diffraktionsanalyse
WO2003034071A2 (en) 2001-10-15 2003-04-24 Therascope Ag A method of forming a dynamic combinatorial library using a scaffold
WO2003086612A1 (en) 2002-04-10 2003-10-23 Ufc Limited Method of producing dynamic combinatorial libraries

Also Published As

Publication number Publication date
AU2003290304A1 (en) 2004-07-14
US20060159226A1 (en) 2006-07-20
DE60311879T2 (de) 2007-12-20
EP1576375B1 (de) 2007-02-14
WO2004057340A1 (en) 2004-07-08
DE60311879D1 (de) 2007-03-29
EP1576375A1 (de) 2005-09-21
US7149280B2 (en) 2006-12-12

Similar Documents

Publication Publication Date Title
ATE375510T1 (de) Screening nach bindepartnern und deren design durch röntgenkristallographie
ATE513218T1 (de) Verfahren zur auswahl von kandidat- drogenverbindungen
WO2002103008A3 (en) Templated molecules and methods for using such molecules
NO20013590D0 (no) Fjernbart filter for oppslemnings-hydrokarbonsynteseprosess
ATE515261T1 (de) Zusammensetzungen zur behandlung von diabetes
ATE501126T1 (de) Verfahren zur herstellung von rosuvastatin
DE60230242D1 (de) Verfahren und Vorrichtung zur Diamantsynthese durch chemische Dampfabscheidung
Scott et al. Oxygen-Bridged Iron-Copper Assemblies Pertinent to Heme-Copper Oxidases: Synthesis and Structure of an [FeIII-(OH)-CuII] Bridge and Exafs Multiple-Scattering Effects of Linear Oxo and Nonlinear Hydroxo Bridges
DE60327356D1 (de) Verfahren zur synthese von metallnanoteilchen
ATE354096T1 (de) Synthese und screening von liganden mit hilfe von röntgenkristallographie
DE60332890D1 (de) In-Situ Röntgendiffraktion zum Screening von Kristallen
DE602004022153D1 (de) Verbindungen zur behandlung von obesitas
FR2630826B1 (fr) Methode pour evaluer la teneur des roches sedimentaires en matiere organique a partir de donnees enregistrees dans des puits par des sondes de diagraphie
DE69938067D1 (de) Verfahren zur Entfernung von organischen Verbindungen mittels Verbrennungskatalysatoren
ATE227262T1 (de) Perfluor-n-alkansulfonsäure-derivate
SE0102384D0 (sv) New compounds
ATE319668T1 (de) Verfahren zur synthese von (2s)-indolin-2- carbonsäure, und verwendung in der synthese von perindopril
ATE523198T1 (de) Pyrroloä2,3-düpyrimidine zur behandlung von krebs durch mitosehemmung
ATE305939T1 (de) Verfahren zur synthese von (2s,3as,7as)-1-((s)-
DK1633861T3 (da) Krystallinsk VAP-1 og anvendelser deraf
ATE280775T1 (de) Verfahren zur synthese von (2s,3as,7as)-1-((s)-
WO2002083938A3 (en) Screening methods for identifying ligands
Yamaguchi et al. A chiral tetranuclear platinum (II) cluster complex,[Pt4 (O2CMe) 4 (pro) 4](Hpro= L-proline)
DE602004029336D1 (de) Verfahren zur herstellung von metallkomplexen
Portillo Iridium-catalyzed hydroamination of allylic amines from aryl amines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties